Our understanding of breast cancer is being transformed

Pharma's incurring bigger and more frequent financial penalties in the US

Healthcare's consuming a larger share of GDP in rich and poor countries alike

Explore the data

Discover the facts and figures from this report

Our interactive graphic allows you to view and compare data for each country mentioned in the report and to compare any six of them.

Download the report

Read the complete analysis

We look at how pharma companies can reach 2020 in a position to benefit from more favourable conditions thereafter - and the most important decisions senior managers will need to make.

Download now